enVVeno Medical Corp.(NVNO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NVNO enVVeno Medical Corp.

Pre-Mkt 12-24 06:20:01 EST

0.3420

+0.0169

+5.20%

High0.3538	Low0.3200	Vol546.35K
Open0.3200	D1 Closing0.3251	Amplitude10.40%
Mkt Cap6.91M	Tradable Cap6.53M	Total Shares20.22M
T/O182.12K	T/O Rate2.86%	Tradable Shares19.09M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NVNO","market":"US","secType":"STK","nameCN":"enVVeno Medical Corp.","latestPrice":0.342,"timestamp":1766523600000,"preClose":0.3251,"halted":0,"volume":546345,"delay":0,"floatShares":19085600,"shares":20216176,"eps":-1.081526,"marketStatus":"Pre-Mkt","change":0.0169,"latestTime":"12-24 06:20:01 EST","open":0.32,"high":0.3538,"low":0.32,"amount":182118.6532269,"amplitude":0.103968,"askPrice":0.3907,"askSize":100,"bidPrice":0.324,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-1.081526,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766586600000},"marketStatusCode":1,"adr":0,"listingDate":1527739200000,"exchange":"NASDAQ","adjPreClose":0.342,"postHourTrading":{"tag":"盘后","latestPrice":0.3401,"preClose":0.342,"latestTime":"19:55 EST","volume":4221,"amount":1435.5586,"timestamp":1766537731964},"volumeRatio":0.7215708265474157,"impliedVol":1.0291,"impliedVolPercentile":0.4137},"requestUrl":"/m/hq/s/NVNO","defaultTab":"news","newsList":[{"id":"2591817156","title":"Director Francis Duhay Reports Disposal of enVVeno Medical Corp. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2591817156","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591817156?lang=en_us&edition=fundamental","pubTime":"2025-12-13 05:40","pubTimestamp":1765575645,"startTime":"0","endTime":"0","summary":"Francis Duhay, Director, reported a disposal of common shares of enVVeno Medical Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL4ZD0HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Francis Duhay Reports Disposal of enVVeno Medical Corp. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2591004689","title":"enVVeno Medical Corp. Held Annual Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2591004689","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591004689?lang=en_us&edition=fundamental","pubTime":"2025-12-13 05:06","pubTimestamp":1765573585,"startTime":"0","endTime":"0","summary":"enVVeno Medical Corp. held its 2025 Annual Meeting of Stockholders on December 11, 2025. Shareholders elected Matthew M. Jenusaitis and Robert A. Berman to the Board of Directors. The appointment of CBIZ CPAs P.C. as the company's registered public accounting firm for the fiscal year ending December 31, 2025 was ratified. Shareholders voted against the adoption of the 2025 Equity Incentive Plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 12, 2025, and is solely responsible for the information contained ther","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL8DBWbM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2586825061","title":"enVVeno Medical CEO to Join Live Virtual Investor CEO Connect Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2586825061","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586825061?lang=en_us&edition=fundamental","pubTime":"2025-11-26 21:50","pubTimestamp":1764165027,"startTime":"0","endTime":"0","summary":"enVVeno Medical Corporation  will participate in a Live Virtual Investor CEO Connect segment on Wednesday, December 3, 2025, at 4:00 PM ET. Chief Executive Officer Robert Berman will provide a corporate overview, discuss recent news and next steps, and answer questions during a live Q&A session. The event will be webcast live on the company's website, with a replay available for 90 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief via ACCESS Newswire  on November 26, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL3mndct:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2585636071","title":"enVVeno Medical Lowers Stockholder Quorum Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2585636071","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585636071?lang=en_us&edition=fundamental","pubTime":"2025-11-21 06:19","pubTimestamp":1763677140,"startTime":"0","endTime":"0","summary":"enVVeno Medical Corp. has amended its bylaws to change the quorum requirement for stockholder meetings. The revised bylaws now state that a quorum is met with the presence, in person or by proxy, of holders of thirty-three and one-third percent of the voting power of outstanding shares entitled to vote. The amendment took effect immediately following approval by the Board of Directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 20, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL8F73t5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2583322545","title":"EnVVeno Medical Loses Appeal of FDA Not-Approvable Letter for VenoValve","url":"https://stock-news.laohu8.com/highlight/detail?id=2583322545","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583322545?lang=en_us&edition=fundamental","pubTime":"2025-11-14 07:44","pubTimestamp":1763077440,"startTime":"0","endTime":"0","summary":"EnVVeno Medical received an unfavorable appeal decision from the Food and Drug Administration, which upheld an August not-approvable letter for VenoValve, a surgical replacement venous valve for treating severe deep chronic venous insufficiency.The medical device company's shares fell 36% to 42 cents after hours.The company said that, assuming it can reach alignment with the FDA on achievable endpoints for another product, enVVe, \"it makes sense to turn our attention and devote our resources to enVVe.\" EnVVeno said \"although the appeal decision was not the result we are looking for, it did provide valuable insight into the criteria that would be necessary for approval of enVVe.\". The company said enVVe, a non-surgical replacement venous valve, should have a different safety profile than an open surgical device and is ready for human testing.With $31.5 million in cash and investments at the end of the third quarter and a quarterly cash burn of $4 million to $5 million, the company said ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"EnVVeno Medical Loses Appeal of FDA Not-Approvable Letter for VenoValve","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2583510859","title":"enVVeno Medical trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2583510859","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583510859?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:55","pubTimestamp":1763070916,"startTime":"0","endTime":"0","summary":"16:55 EST enVVeno Medical (NVNO) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/envveno-medical-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/envveno-medical-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2579310535","title":"enVVeno Medical Corp - May Sell up to $50 Mln of Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2579310535","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579310535?lang=en_us&edition=fundamental","pubTime":"2025-10-31 05:37","pubTimestamp":1761860265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WB2R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2579722161","title":"enVVeno Medical Corp. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2579722161","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579722161?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:18","pubTimestamp":1761855510,"startTime":"0","endTime":"0","summary":"enVVeno Medical Corp. has announced that it will hold its 2025 Annual Meeting of Stockholders via live webcast on December 11, 2025. The meeting will include proposals for shareholders to consider and vote on.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 30, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL4GFVrS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2578974649","title":"enVVeno Medical Corp  expected to post a loss of 30 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2578974649","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578974649?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:49","pubTimestamp":1761569359,"startTime":"0","endTime":"0","summary":"enVVeno Medical Corp  expected to post a loss of30cents a share - Earnings Preview enVVeno Medical Corp NVNO.OQ NVNO.O is expected to  show no change in quarterly revenue when it reports  results on O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nL8N3W8107:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2574127533","title":"enVVeno Medical Corp receives Nasdaq notice for failing to meet minimum bid price requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2574127533","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574127533?lang=en_us&edition=fundamental","pubTime":"2025-10-10 18:31","pubTimestamp":1760092269,"startTime":"0","endTime":"0","summary":"enVVeno Medical Corp. announced that it has received a notice from the Nasdaq Stock Market indicating that the company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The notice was issued after the closing bid price of enVVeno's common stock remained below $1.00 per share for 30 consecutive business days. The company has 180 calendar days, until April 6, 2026, to regain compliance by having its stock close at or above $1.00 per share for at least 10 consecutive trading days. If compliance is not achieved by then, enVVeno may be eligible for an additional 180-day period to meet the requirement. The notice does not have an immediate effect on the company's Nasdaq listing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL63qWLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVNO","BK4082"],"gpt_icon":0},{"id":"2570857098","title":"enVVeno Medical Corp. Files Supervisory Appeal After FDA Issues Not-Approvable Letter for VenoValve® PMA; Ongoing Regulatory Review Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2570857098","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570857098?lang=en_us&edition=fundamental","pubTime":"2025-09-26 20:45","pubTimestamp":1758890716,"startTime":"0","endTime":"0","summary":"enVVeno Medical Corp. Files Supervisory Appeal After FDA Issues Not-Approvable Letter for VenoValve PMA; Ongoing Regulatory Review Continues. **enVVeno Medical Corp. Requests FDA Supervisory Appeal for VenoValve Approval** Irvine, CA, September 26, 2025 - enVVeno Medical Corp.  has announced it is pursuing a supervisory appeal with the U.S. Food & Drug Administration  following the receipt of a not-approvable letter from the agency's Center for Devices and Radiological Health  regarding its Premarket Approval  application for the VenoValve. The VenoValve is a surgical replacement venous valve designed to treat severe deep chronic venous insufficiency . No new grant or funding has been reported, and the regulatory review pertains solely to enVVeno Medical Corp.'s device. CEO Robert Berman discussed the ongoing regulatory process during a recent Virtual Investor \"What This Means\" segment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intellige","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDL10QMMJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2567114794","title":"enVVeno Medical to file request for appeal of CDRH non-approvable letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2567114794","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567114794?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:50","pubTimestamp":1757940606,"startTime":"0","endTime":"0","summary":"enVVeno Medical (NVNO) will file a request for supervisory appeal of the not-approvable letter from the Center for Devices and Radiological Health ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/envveno-medical-to-file-request-for-appeal-of-cdrh-non-approvable-letter-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/envveno-medical-to-file-request-for-appeal-of-cdrh-non-approvable-letter-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","NVNO"],"gpt_icon":0},{"id":"2567509114","title":"enVVeno Medical Corp. Files Supervisory Appeal with FDA for VenoValve® Approval Following Not-Approvable Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2567509114","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567509114?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:45","pubTimestamp":1757940319,"startTime":"0","endTime":"0","summary":"enVVeno Medical Corp. has announced plans to file a request for supervisory appeal following a not-approvable letter from the Center for Devices and Radiological Health  of the U.S. Food & Drug Administration  regarding its Premarket Approval  application for the VenoValve. The device is a surgical replacement venous valve aimed at treating severe deep chronic venous insufficiency . enVVeno Medical, which has an established working relationship with the FDA through its previous interactions for Breakthrough Device Designation and Investigational Device Exemption, views this appeal as an opportunity to address issues collaboratively. The company is optimistic that presenting their data in a supervisory appeal will lead to a favorable decision by the end of 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDLb7zH5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVNO","BK4082"],"gpt_icon":0},{"id":"2561413516","title":"EnVVeno Medical Shares Fall After Ladenburg Thalmann Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2561413516","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561413516?lang=en_us&edition=fundamental","pubTime":"2025-08-22 03:04","pubTimestamp":1755803043,"startTime":"0","endTime":"0","summary":"EnVVeno Medical's  shares were down 17% in recent Thursday trading after Ladenburg Thalmann downgraded the healthcare company's stock to neutral from buy.Intraday trading volume stood at about 6.4 million shares against a daily average of 369,000 shares.Price: 0.97, Change: -0.20, Percent Change: -16.84","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVNO"],"gpt_icon":0},{"id":"2561467476","title":"Ladenburg Thalmann Downgrades enVVeno Medical to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2561467476","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561467476?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:09","pubTimestamp":1755778147,"startTime":"0","endTime":"0","summary":"enVVeno Medical (NVNO) has an average rating of Buy and mean price target of $12.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVNO"],"gpt_icon":0},{"id":"2561486890","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2561486890","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561486890?lang=en_us&edition=fundamental","pubTime":"2025-08-21 02:36","pubTimestamp":1755714967,"startTime":"0","endTime":"0","summary":"James Hardie Industries (JHX) shares slumped 36% after the company reported late Tuesday a year-over-year decline in fiscal Q1 adjusted earnings and sales.Truist cuts its price target on the stock to ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7044","JHX","NVNO","BK4082","CLDI","JHX.AU","BK4011","BK4139"],"gpt_icon":0},{"id":"2561756488","title":"BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, silver miners, oil firms","url":"https://stock-news.laohu8.com/highlight/detail?id=2561756488","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561756488?lang=en_us&edition=fundamental","pubTime":"2025-08-21 00:44","pubTimestamp":1755708245,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, silver miners, oil firmsEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nL6N3UC0MT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DAY","JHX.AU","TGT","SG9999001440.SGD","ADI","CLDX","MSC","SISI","TOL","EL","HL","RCKT","HTZ","ELPW","COP","APA","XOM","LZB","PSQH","CVX","NEM","ADM","REGN","AU","LU0788109394.HKD","AHL","CAR","NVNO","BG","LU1623119135.USD","GAP","MDT","UPLD","LOW","SNOW","TJX","00200","DY","EU","ALTS","JFIN","CTOS","NESR","CDE"],"gpt_icon":1},{"id":"2560886170","title":"enVVeno Medical: FDA Also Focused on Safety Concerns Attributed to Venovalve Open Surgical Procedure","url":"https://stock-news.laohu8.com/highlight/detail?id=2560886170","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560886170?lang=en_us&edition=fundamental","pubTime":"2025-08-20 19:11","pubTimestamp":1755688273,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UC0JO:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVNO","BK4082"],"gpt_icon":0},{"id":"2560880170","title":"enVVeno Medical Corp - Receives Not-Approvable Letter From FDA for Venovalve - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2560880170","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560880170?lang=en_us&edition=fundamental","pubTime":"2025-08-20 19:11","pubTimestamp":1755688273,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UC0JO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVNO","BK4082"],"gpt_icon":0},{"id":"2560708821","title":"enVVeno Medical Corp: Reviewing Feedback From FDA and Is Assessing All Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2560708821","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560708821?lang=en_us&edition=fundamental","pubTime":"2025-08-20 19:11","pubTimestamp":1755688273,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UC0JO:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NVNO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.envveno.com","stockEarnings":[{"period":"1week","weight":0.0698},{"period":"1month","weight":0.0427},{"period":"3month","weight":-0.6489},{"period":"6month","weight":-0.918},{"period":"1year","weight":-0.8825},{"period":"ytd","weight":-0.8868}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0439},{"period":"3month","weight":0.0406},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.1568},{"period":"ytd","weight":0.1738}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.048758},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.007869},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.097721},{"month":4,"riseRate":0.428571,"avgChangeRate":0.053162},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.090051},{"month":6,"riseRate":0.625,"avgChangeRate":-0.025286},{"month":7,"riseRate":0.625,"avgChangeRate":0.100556},{"month":8,"riseRate":0.5,"avgChangeRate":-0.037063},{"month":9,"riseRate":0.625,"avgChangeRate":0.017272},{"month":10,"riseRate":0.25,"avgChangeRate":-0.160694},{"month":11,"riseRate":0.125,"avgChangeRate":-0.179267},{"month":12,"riseRate":0.375,"avgChangeRate":0.034328}],"exchange":"NASDAQ","name":"enVVeno Medical Corp.","nameEN":"enVVeno Medical Corp."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"enVVeno Medical Corp.(NVNO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest enVVeno Medical Corp.(NVNO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"enVVeno Medical Corp.,NVNO,enVVeno Medical Corp.股票,enVVeno Medical Corp.股票老虎,enVVeno Medical Corp.股票老虎国际,enVVeno Medical Corp.行情,enVVeno Medical Corp.股票行情,enVVeno Medical Corp.股价,enVVeno Medical Corp.股市,enVVeno Medical Corp.股票价格,enVVeno Medical Corp.股票交易,enVVeno Medical Corp.股票购买,enVVeno Medical Corp.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"enVVeno Medical Corp.(NVNO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest enVVeno Medical Corp.(NVNO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction